Association of severity of conjunctival and corneal calcification with all-cause 1-year mortality in maintenance haemodialysis patients.

BACKGROUND Conjunctival and corneal calcification (CCC) is the most common form of metastatic calcification in patients with chronic renal failure. The aim of this study is to investigate if severity of CCC correlates with vascular calcification and mortality in maintenance haemodialysis (MHD) patients. METHODS One hundred and nine MHD patients were recruited. CCC was evaluated by external eye photographs, and was graded and scored according to modified Porter and Crombie classification system described by Tokuyama et al. Chest X-ray examination was used to evaluate aortic arch calcification. Geographic, haematological, biochemical and dialysis-related data were obtained. The patients were analysed for traditional and non-traditional risk factors for cardiovascular disease stratified by severity of CCC. All patients were followed up for 1 year to investigate the risks for mortality. RESULTS Forty-three, 35 and 31 patients had mild (scores ≤ 4), moderate and severe (scores ≥ 9) CCC at baseline, respectively. With trend estimation, patients with severe CCC had a significantly higher percentage of severe aortic arch calcification. Multiple linear regression analysis showed that hypertension, haemodialysis duration and corrected calcium level were associated with scores of CCC in MHD patients. Moreover, age, corrected calcium-phosphate level, and moderate and severe CCC were associated with grades of aortic arch calcification. At 1-year follow-up, 11 of 109 (10.1%) patients had died. Multivariate Cox proportional hazards model showed that age, corrected calcium and severe CCC were significant risk factors for all-cause 1-year mortality in MHD patients. Each increment of one score of CCC is associated with a 26.4% increased risk for all-cause mortality. CONCLUSIONS Severity of CCC, which is easily obtained at bedside, acts as an independent predictor for all-cause 1-year mortality in MHD patients.

[1]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[2]  G. Mavridis,et al.  Gravity of aortic arch calcification as evaluated in adult Greek patients. , 2002, International angiology : a journal of the International Union of Angiology.

[3]  J T Daugirdas,et al.  The post: pre dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: validation. , 1989, The International journal of artificial organs.

[4]  M. Inaba,et al.  Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  N. Seyahi,et al.  Association of conjunctival and corneal calcification with vascular calcification in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  P. Raggi,et al.  Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification. , 2004, Clinical nephrology.

[7]  Seoung Woo Lee,et al.  Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  K. Kalantar-Zadeh.  Recent Advances in Understanding the Malnutrition‐Inflammation‐Cachexia Syndrome in Chronic Kidney Disease Patients: What is Next? , 2005, Seminars in dialysis.

[9]  Takashi Akiba,et al.  Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  A. Crombie,et al.  Corneal and conjunctival calcification in chronic renal failure. , 1973, The British journal of ophthalmology.

[11]  G. de Venecia,et al.  Calcific eyelid margin lesions in chronic renal failure. , 1989, American journal of ophthalmology-glaucoma.

[12]  J A Sargent,et al.  Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study. , 1983, Kidney international. Supplement.

[13]  G. Chertow.  Slowing the progression of vascular calcification in hemodialysis. , 2003, Journal of the American Society of Nephrology : JASN.

[14]  G. O'Connor.  Calcific band keratopathy. , 1972, Transactions of the American Ophthalmological Society.

[15]  P. Raggi,et al.  Factors associated with mortality in patients new to haemodialysis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  O. P. van Bijsterveld,et al.  Limbal and corneal calcification in patients with chronic renal failure. , 1993, The British journal of ophthalmology.

[17]  P. Raggi,et al.  Determinants of progressive vascular calcification in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  O. Mimura,et al.  Conjunctival and corneal calcification and bone metabolism in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  E. Lonn,et al.  Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  A. Carceller,et al.  Corneal Disease in Patients With Chronic Renal Insufficiency Undergoing Hemodialysis , 2001, Cornea.

[21]  A. Dusso,et al.  Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. , 2001, Journal of the American Society of Nephrology : JASN.

[22]  G. London.  Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. , 2003, Journal of the American Society of Nephrology : JASN.

[23]  D. Towler,et al.  Vascular calcification: the killer of patients with chronic kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[24]  Ross Ward,et al.  United States Renal Data System , 2011 .

[25]  O. P. Bijsterveld,et al.  A local challenger of ocular calciphylaxis in patients with chronic renal failure: a hypothesis , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  O. Gr.  Calcific band keratopathy. , 1972, Transactions of the American Ophthalmological Society.

[27]  S. Oto,et al.  Impression cytology of the conjunctival epithelium in patients with chronic renal failure , 2000, The British journal of ophthalmology.

[28]  C. Giachelli,et al.  Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench , 2005, Current opinion in nephrology and hypertension.

[29]  R. Agarwal.  Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient. , 2007, Current opinion in nephrology and hypertension.

[30]  P. Stenvinkel,et al.  Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  Edward T H Yeh,et al.  Coming of age of C-reactive protein: using inflammation markers in cardiology. , 2003, Circulation.

[32]  P. Raggi,et al.  Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. , 2007, Kidney international.

[33]  C. Wanner,et al.  C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  P. Parfrey,et al.  The clinical epidemiology of cardiovascular disease in chronic kidney disease , 2005, Current opinion in nephrology and hypertension.

[35]  P. Raggi,et al.  Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. , 2004, The Journal of heart valve disease.

[36]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  Richardson Js,et al.  Conjunctival and corneal changes in chronic renal failure. , 1974 .

[38]  S. Ganesh,et al.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. , 2001, Journal of the American Society of Nephrology : JASN.

[39]  A. Covic,et al.  Causes and Consequences of Increased Arterial Stiffness in Chronic Kidney Disease Patients , 2007, Kidney and Blood Pressure Research.

[40]  Sargent Ja,et al.  Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study. , 1983 .

[41]  Patient mortality and survival. United States Renal Data System. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[44]  N. Akyürek,et al.  Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure , 2007, Nephrology.